Scientists test common drug Mix-Ups in healthy volunteers
NCT ID NCT07196449
Summary
This study aims to understand how two common drugs, rifampicin (an antibiotic) and cyclosporine (an immunosuppressant), change how the body processes methotrexate, a medication used for cancer and autoimmune diseases. Researchers will give these drug combinations to 12 healthy volunteers and measure drug levels in their blood. The goal is to identify potential dangerous interactions to help doctors prescribe methotrexate more safely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG DRUG INTERACTION (DDI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13605, South Korea
Conditions
Explore the condition pages connected to this study.